Table 1

Overview of sample numbers in each subject group, treatment arm, sampling time point and response group

CTX participantsHSCT participantsAll SSc
Death/organ failureSurvived event-freeTotal CTXDeath/organ failureSurvived event-freeTotal HSCTTotal
No of participants1517326253163
Time pointCTX time pointsHSCT time pointsAll SSc time points
Death/organ failureSurvived event-freeTotal CTXDeath/Organ failureSurvived event-freeTotal HSCTTotal (per time point)
Baseline1517326253163
T1m0001011
T14m4043037
T20m3031014
T26m814221222345
T38m412160212137
T44m1010001
T48m011110191930
T54m0110334
Total3555901290102192
  • A total of 192 serum samples from 63 SCOT participants were available. The table provides a detailed overview of sample numbers per time point for each treatment arm.

  • CTX, cyclophosphamide; HSCT, haematopoietic stem cell transplant; SCOT, haematopoietic stem cell transplant; SSc, systemic sclerosis.